General Information of the Compound
| Compound ID |
CP0047116
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-(1-phenyl-2-(2-propoxyphenyl)ethyl)piperazine
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-(1-phenyl-2-(2-propoxyphenyl)ethyl)piperazine
CHEMBL213754
SCHEMBL5447617
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H28N2O
|
||||||||||||||||||
| Molecular Weight |
324.468
|
||||||||||||||||||
| Canonical SMILES |
CCCOc1ccccc1CC(N1CCNCC1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H28N2O/c1-2-16-24-21-11-7-6-10-19(21)17-20(18-8-4-3-5-9-18)23-14-12-22-13-15-23/h3-11,20,22H,2,12-17H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
PSIGDYKJTYBHDY-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00884, Sodium-dependent dopamine transporter
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Protein ID: PT00871, Sodium-dependent serotonin transporter
Clinical Information about the Compound
Drug 1 ( 1-(1-phenyl-2-(2-propoxyphenyl)ethyl)piperazine )
| Drug Name | 1-(1-phenyl-2-(2-propoxyphenyl)ethyl)piperazine | ||
|---|---|---|---|
| Target(s) | |||